Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine

Published:2021-09-27 Issue:0 Volume:0 Page:
ISSN:2191-0286
Container-title:Journal of Basic and Clinical Physiology and Pharmacology
language:en
Short-container-title:

Author:

Crocetto Felice¹,Cimmino Amelia²,Ferro Matteo³,Terracciano Daniela⁴^ORCID

Affiliation:

1. Department of Neurosciences, Sciences of Reproduction and Odontostomatology , University of Naples Federico II , Naples , Italy

2. Institute of Genetics and Biophysics, National Research Council , Naples , Italy

3. Department of Urology of European Institute of Oncology (IEO) , IRCCS , Milan , Italy

4. Department of Translational Medical Sciences , University of Naples “Federico II” , Naples , Italy

Publisher

Walter de Gruyter GmbH

Subject

Drug Discovery,Pharmacology,General Medicine,Physiology

Link

https://www.degruyter.com/document/doi/10.1515/jbcpp-2021-0233/pdf

Reference33 articles.

1. Azevedo, R, Peixoto, A, Gaiteiro, C, Fernandes, E, Neves, M, Lima, L, et al.. Over forty years of bladder cancer glycobiology: where do glycans stand facing precision oncology? Oncotarget 2017;8:91734–64. https://doi.org/10.18632/oncotarget.19433.

2. Ferro, M, Baba, DF, de Cobelli, O, Musi, G, Lucarelli, G, Terracciano, D, et al.. Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy. Future Sci OA 2021;7:FSO709. https://doi.org/10.2144/fsoa-2021-0008.

3. Hu, F, Mao, X, Zhang, Y, Zheng, X, Gu, P, Wang, H, et al.. Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review. OncoTargets Ther 2018;11:1373–84. https://doi.org/10.2147/ott.s158479.

4. Huang, H, Shi, Y, Huang, J, Wang, X, Zhang, R, Chen, H. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis. Clin Respir J 2018;12:639–45. https://doi.org/10.1111/crj.12573.

5. Tan, Y, Wu, H. The significant prognostic value of circulating tumor cells in colorectal cancer: a systematic review and meta-analysis. Curr Probl Canc 2018;42:95–106. https://doi.org/10.1016/j.currproblcancer.2017.11.002.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The predictive value of PFKFB3 in bladder cancer prognosis;Heliyon;2024-05

2. Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring;International Journal of Molecular Sciences;2024-03-30

3. Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis;BMC Urology;2024-03-11

4. Urine cytology: Updates and challenges in reporting systems, ancillary studies, and artificial intelligence;Human Pathology Reports;2024-03

5. Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer;Diagnostics;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3